Choroidal Neovascularization Secondary to Pathologic Myopia
📧 Sign up to get email alerts when something new happens for Choroidal Neovascularization Secondary to Pathologic Myopia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia [Phase 3]
Phase 3 study evaluating Faricimab for choroidal neovascularization secondary to pathologic myopia is active but not recruiting (NCT06176352…